Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sinco Pharmaceutical HoldingsHKSE:06833 -0.60%44 Days Inventory is 60.73 as of Dec. 2025, which is 27% above its 10-year median of 47.65. GuruFocus rates HKSE:06833 with a GF Score™ of 44/100 and a GF Value™ of HK$0.19 (Modestly Undervalued). The stock has 6 warning signs investors should review. Among 117 Medical Distribution companies, Sinco Pharmaceutical Holdings ranks worse than 52.99% on this metric.
The historical rank and industry rank for Sinco Pharmaceutical Holdings's Days Inventory or its related term are showing as below:
HKSE:06833'
s Days Inventory Range Over the Past 10 Years
Min: 14.42 Med: 47.65 Max: 129.3
Current: 57.26
During the past 12 years, Sinco Pharmaceutical Holdings's highest Days Inventory was 129.30. The lowest was 14.42. And the median was 47.65.
HKSE:06833's Days Inventory is ranked worse than 52.99% of 117
companies
in the Medical Distribution industry
Industry Median: 54.88
vs HKSE:06833: 57.26
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinco Pharmaceutical Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 was 3.00.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinco Pharmaceutical Holdings's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.30.
Sinco Pharmaceutical Holdings (HKSE:06833) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Sinco Pharmaceutical Holdings's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Sinco Pharmaceutical Holdings's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Sinco Pharmaceutical Holdings Days Inventory Related Terms
Sinco Pharmaceutical Holdings Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinco Pharmaceutical Holdings Days Inventory Chart
HKSE:06833 vs MCK, COR, CAH: Days Inventory Comparison
For the Medical Distribution subindustry, Sinco Pharmaceutical Holdings's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinco Pharmaceutical Holdings Days Inventory vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinco Pharmaceutical Holdings's Days Inventory distribution charts can be found below:
* The bar in red indicates where Sinco Pharmaceutical Holdings's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sinco Pharmaceutical Holdings (HKSE:06833) has a Days Inventory of 60.73 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinco Pharmaceutical Holdings and its competitors. This is 27% above median its historical median of 47.65. Over the past decade, Sinco Pharmaceutical Holdings' Days Inventory has ranged from 14.42 to 129.30. According to the industry distribution chart, Sinco Pharmaceutical Holdings ranks #62 out of 117 companies in the Medical Distribution industry, placing it in the top 53%.
Is Sinco Pharmaceutical Holdings' Days Inventory too high?
Sinco Pharmaceutical Holdings' current Days Inventory of 60.73 is 27% above median its 10-year median of 47.65. Over the past 10 years, this metric has ranged from a low of 14.42 to a high of 129.30. The Medical Distribution industry median Days Inventory is 54.88. Sinco Pharmaceutical Holdings' value of 60.73 is 10.7% above this industry median. Based on the distribution chart, Sinco Pharmaceutical Holdings ranks #62 out of 117 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Sinco Pharmaceutical Holdings has a GF Score™ of 44/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sinco Pharmaceutical Holdings' Days Inventory compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Sinco Pharmaceutical Holdings ranks #62 out of 117 companies for Days Inventory. This places Sinco Pharmaceutical Holdings in the lower half of its industry. The industry median Days Inventory is 54.88. Sinco Pharmaceutical Holdings' value of 60.73 is 10.7% above this benchmark. Historically, Sinco Pharmaceutical Holdings' own Days Inventory has ranged from 14.42 to 129.30 over the past decade. While the company's 10-year median is 47.65 vs. the industry median of 54.88, Sinco Pharmaceutical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Distribution company?
The median Days Inventory among Medical Distribution companies is 54.88, based on 117 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sinco Pharmaceutical Holdings's current Days Inventory of 60.73 is 10.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Sinco Pharmaceutical Holdings and its competitors. For the Medical Distribution industry, the median Days Inventory is 54.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sinco Pharmaceutical Holdings's current Days Inventory is 60.73, which is 27% above median its own 10-year median of 47.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sinco Pharmaceutical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Sinco Pharmaceutical Holdings (HKSE:06833) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.19, compared to a current price of HK$0.17 — trading 12.6% below its estimated fair value. The current Days Inventory is 60.73, which is 27% above median its 10-year median of 47.65 and 10.7% above the Medical Distribution industry median of 54.88. Sinco Pharmaceutical Holdings' overall GF Score™ is 44/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Sinco Pharmaceutical Holdings (HKSE:06833), the current Days Inventory is 60.73 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sinco Pharmaceutical Holdings (HKSE:06833) Overvalued in 2026?
Based on GuruFocus' analysis, Sinco Pharmaceutical Holdings stock appears to be undervalued.
The current stock price of HK$0.17 is trading 12.6% below its estimated GF Value™ of HK$0.19.
GuruFocus considers Sinco Pharmaceutical Holdings to be Modestly Undervalued.
Key valuation signals for HKSE:06833:
Days Inventory: 60.73 (27% above median its 10-year median of 47.65)
GF Value™: HK$0.19 vs. price of HK$0.17 (12.6% below fair value)
Industry Position: 10.7% above the Medical Distribution median (#62 of 117)
No single metric tells the full story. See the HKSE:06833 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sinco Pharmaceutical Holdings Ltd is an investment holding company that deals in marketing, promotion, and channel management of improved human plasma-based pharmaceuticals, antibiotics, and other pharmaceuticals. The company operates in three business segments, namely biologics, medical aesthetic products, and biopharmaceutical cold chain and supply chain services. The biologics business provides marketing, promotion, and channel management services, while the medical aesthetic products business focuses on research and development, production, and sales of aesthetic medicine in China. The biopharmaceutical cold chain and supply chain services concentrate on the construction of cold chain facilities for biopharmaceutical products and establishing the supply chain service platform.
44GF Score
Get the complete analysis for HKSE:06833
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06833 has been successfully added to your 
